Prepared by: Dante Fichera
CapitalHunter.com has launched its new website with new functionalities. Please visit our website and see what free new powerful research and news features have been added for your use.
“What’s Hot” this reporting period are venture backed companies based in California operating in the biotechnology industry and have raised their Series C of financing.
No IPO’s this week…
|
 |
CapitalHunter.com was able to verified that $215 million of venture capital was invested in 19 U.S.-based companies during this week’s reporting period. The average deal size was approximately $11.32 million. The amount of venture capital invested this period decreased by 43% from last week’s $337 million. Have a great Labor Day weekend. Can you believe that summer is already over? |
|
|
 |
Geographically, 9 California companies raised $119.3 million in venture financings. The largest private venture financing in California this period was into MediciNova raised $44 million. MediciNova is a specialty pharmaceutical company focused on acquiring and accelerating the global development and commercialization of innovative pharmaceutical products. |
|
|
 |
The Biotechnology sector raised 38% of the venture capital this period. Three Communications company raised $83 million in venture financing. MediciNova was the largest financing in this category. |
|
|
 |
Companies raising their Series C round of financing led this week’s venture capital activity. Series C financings represented 42% of the total venture capital deployed this period. The largest later stage financing was into MediciNova.
|
|
|
 |
|
The three largest venture deals this period are as follows: |
| |
Company |
Industry |
Investment |
| 1 |
MediciNova |
Biotechnology |
$44 million |
| 2 |
COPAN Systems |
Network and Equipment |
$25 million |
| 3 |
Enanta Pharmaceuticals |
Biotechnology |
$20 million |
|
 |
The following thirteen and other unnamed investors funded the above mentioned top three venture capital investments for $89 million: |
| 1 | Aqua RIMCO Biovision Life Science Fund | | 2 | China Development Industrial Bank | | 3 | Diamond Capital Management | | 4 | Dr. Ci Labo | | 5 | Essex Woodlands Health Ventures | | 6 | J F E Hottinger | | 7 | Mizuho Securities | | 8 | New Business Investment | | 9 | NIF Ventures | | 10 | Nippon Venture Capital | | 11 | POSCO BioVentures | | 12 | SMBC Capital | | 13 | The University of Tokyo Capital |
|
A total of 33 worldwide equity financings of private and public companies occurred during this reporting period. Each of the 33 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s. Also available is access to over 30,000 other historic equity financings through the CapitalHunter.com searchable database.
About CapitalHunter.com
CapitalHunter.com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the CapitalHunter.com searchable database to research newly and historic financings and to identify active investors.
|
|
|
|
©2003 Capital Hunter, Inc. all rights reserved
|
To be REMOVED from this free service, CLICK HERE |